Chelsea Trengrove, PhD, CEO and Cofounder

Dr. Chelsea Trengrove, with a Ph.D. in Neuroscience, brings a multidimensional expertise spanning academia, industry, and entrepreneurship. Her tenure at prominent institutions like Regeneron Pharmaceuticals and MIT spin-out, Empatica Inc., underscores her knack for crafting strategic partnerships and influencing stakeholder decisions. Beyond her scientific acumen, Chelsea's vast network and business development insights are paramount to Neoclease. Her expansive network and keen business acumen position Neoclease at the forefront of innovation, ensuring the company's continued growth and the swift advancement of its pioneering enzymatic libraries.

Professor Jin Liu, PhD, CTO and Cofounder

Dr. Liu, received her PhD in Computational Chemistry from The Ohio State University, and completed postdoctoral training at National Cancer Institute-Frederick, NIH. Prior to her current position, she worked at U.S. Army Medical Research and Materiel Command, University of Texas Southwestern Medical Center, and held a faculty position at Southern Methodist University. She's now a tenured professor at UNTHSC, running a lab focused on synthetic biology, AI, and genetic engineering. Her expertise in molecular dynamics simulations, nuclease specificity enhancement, and AI-driven solutions positions her at the forefront of our technologic development. 

Dr. Liu's Research and Publications